iSOFT Expands in Russia after Agreement with ML Park

iSOFTiSOFT Deutschland has strengthened its position in Russia's healthcare market after a partnership agreement with ML Park of Moscow to distribute and support iSOFT's laboratory information systems (LIS). The market in Russia offers huge potential and is set to grow at unprecedented rates. The Russian market for medical technology is worth US$2 billion a year and is growing by about 15 per cent per annum. The 'National Health Programme', which was initiated by president Putin (until 2010) provides US$1.7 billion to build 15 specialised health centres.

iSOFT has already installed its LabCentre laboratory system at KDL Test, a private laboratory chain with laboratories in Moscow, Omsk, Perm and Krasnodar. ML Park and KDL Test are sister companies and both are subsidiaries of ML Group.

iSOFT Deutschland, part of the IBA Health Group – the world's fourth largest healthcare IT provider – will focus on providing modern laboratory software solutions in Russia. Peter Herrmann, Managing Director, iSOFT Deutschland, said: "Through our partnership with ML Park we can support our Russian laboratory customers locally and develop systems to meet local needs. An early presence in this booming healthcare market is absolutely necessary. For us, this will be the basis for more efficient market cultivation and a fast and wide market penetration with our solutions.

ML Park's knowledge of laboratory systems and the private LIS market in Russia will be invaluable in establishing a support organisation in Russia."

Core elements of the agreement are the distribution, implementation and support of the leading iSOFT laboratory solution, LabCentre. iSOFT is the market leader in laboratory information systems with more than 270 installations in Germany, Switzerland, Austria, Russia and Malaysia. LabCentre is a full-graphic integrated system, covering clinical laboratory, blood donation and microbiology.

Related news articles:

About iSOFT
Following a merger completed on Tuesday 30 October, iSOFT is now part of the IBA Health Group. For further information, please visit http://www.ibahealth.com.

iSOFT products are used by more than 8,000 organisations in 27 countries for managing patient information and driving improvements in healthcare services. For further information, please visit http://www.isoftplc.com.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...